Capital Blue CrossCommercial · Prior Auth · Medical Policy · Cardiology, Dermatology, Genetics +7 moreHigh impact
AB2026-11-005 Medical policies
Act
by Dec 1, 2026
Effective date
Dec 1, 2026
Identified
Oct 31, 2026
Summary
Capital Blue Cross administrative bulletin 2026-11-005, dated November 1, 2026, lists medical policy updates with an effective date of December 1, 2026 unless otherwise indicated. Changes effective December 1, 2026 include added procedure codes in the Durable Medical Equipment policy and new preauthorization requirements for several Prime Therapeutics injectables. Many other changes take effect January 1, 2027, including EviCore's Clinical Guidelines for Lab Management Program, Version 1.0.2027, updated Evolent radiology and radiation oncology guidelines, and updated TurningPoint musculoskeletal and cardiology policies.
Get alerts when payers change rules like this one
We check Capital Blue Cross and other payers every day and email you when a change matches your specialty and state.
01Get preauthorization for the injectables the source says now require it, and submit requests through the Prime MPS GatewayPA Portal.
02These include J9999 and C9399 for Revtorpyk, J3590 and C9399 for Tregzi and Lumvoa, J3590 for Lytenava, and Q5154 for Omlyclo.
03Check the Capital Blue Cross Single Source Preauthorization List on the CapBlueCross.com provider web page for the full list of codes that require preauthorization.
04Changes to the EviCore, Evolent and TurningPoint guidelines take effect January 1, 2027, so read the bulletin at the source link for those details.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.